Hjem › KOL
KOL kliniske forsøg rekrutterer i USA
98 studier for KOL rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Philadelphia, PA23 studier
- Miami, FL18 studier
- Birmingham, AL17 studier
- Boston, MA17 studier
- Orlando, FL15 studier
- Houston, TX15 studier
- Baltimore, MD14 studier
- Chicago, IL14 studier
- Dallas, TX12 studier
- Pittsburgh, PA12 studier
- New York City, NY11 studier
- Ann Arbor, MI10 studier
- Detroit, MI9 studier
- Los Angeles, CA9 studier
- Winston-Salem, NC9 studier
- Charlotte, NC9 studier
- Phoenix, AZ9 studier
- Kansas City, KS9 studier
- Hialeah, FL8 studier
- Newport Beach, CA8 studier
- Columbus, OH8 studier
- Cleveland, OH8 studier
- Nashville, TN7 studier
- Tampa, FL7 studier
- Durham, NC7 studier
- Kendall, FL7 studier
- Denver, CO7 studier
- Milwaukee, WI7 studier
- Farmington Hills, MI6 studier
- West Palm Beach, FL6 studier
- Jacksonville, FL6 studier
- Indianapolis, IN6 studier
- Aurora, CO6 studier
- Shreveport, LA5 studier
- El Paso, TX5 studier
- Las Vegas, NV5 studier
- St. Louis, MO5 studier
- Baton Rouge, LA5 studier
- Atlanta, GA5 studier
- Spartanburg, SC5 studier
Efter delstat
- Alabama21 studier
- Arizona17 studier
- Californien26 studier
- Colorado15 studier
- Connecticut3 studier
- Florida28 studier
- Georgia12 studier
- Idaho4 studier
- Illinois19 studier
- Indiana10 studier
- Iowa6 studier
- Kansas12 studier
- Kentucky5 studier
- Louisiana9 studier
- Maine3 studier
- Maryland16 studier
- Massachusetts25 studier
- Michigan22 studier
- Minnesota11 studier
- Mississippi3 studier
- Missouri7 studier
- Montana3 studier
- Nebraska5 studier
- Nevada8 studier
- New Jersey7 studier
- New York19 studier
- North Carolina22 studier
- Ohio17 studier
- Oklahoma8 studier
- Oregon6 studier
- Pennsylvania33 studier
- South Carolina14 studier
- South Dakota6 studier
- Tennessee14 studier
- Texas25 studier
- Utah6 studier
- Vermont5 studier
- Virginia12 studier
- Washington6 studier
- West Virginia5 studier
- Wisconsin8 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 2. okt. 2026 · NCT06283966Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Rekrutterer
Alder 40 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07072039Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 1. okt. 2026 · NCT07190222WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Rekrutterer
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07558265To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
RekruttererFase 2
Alder 40 til 85 · Alle køn · Opdateret 30. sep. 2026 · NCT07684820Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
Rekrutterer
Alder 40 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT05934565A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
RekruttererFase 2
Alder 40 til 80 · Alle køn · Opdateret 25. sep. 2026 · NCT07725939A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 25. sep. 2026 · NCT07780656: Vascular Function in Health and Disease
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT02966665A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 2
Alder 40 til 75 · Alle køn · Opdateret 25. sep. 2026 · NCT07759245Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 22. sep. 2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
RekruttererFase 4
Alder 40 til 85 · Alle køn · Opdateret 22. sep. 2026 · NCT07053423A Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 21. sep. 2026 · NCT07793409An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Rekrutterer
Alder 40 til 80 · Alle køn · Opdateret 17. sep. 2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
RekruttererFase 2
Alder 40 til 80 · Alle køn · Opdateret 15. sep. 2026 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
RekruttererFase 4
Alder 60 og opefter · Alle køn · Opdateret 14. sep. 2026 · NCT07816835A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 9. sep. 2026 · NCT07780669A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
RekruttererFase 2
Alder 40 og opefter · Alle køn · Opdateret 4. sep. 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
RekruttererFase 3
Alder 40 til 80 · Alle køn · Opdateret 3. sep. 2026 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT06603246COPD Exacerbation Follow Up
RekruttererObservationsstudie
Alder 40 og opefter · Alle køn · Opdateret 2. sep. 2026 · NCT07118306The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
RekruttererObservationsstudie
Alder 40 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
RekruttererFase 2/3
Alder 35 til 80 · Alle køn · Opdateret 31. aug. 2026 · NCT07363694Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.